TYO: 4502

Takeda Q3 Revenue Drops 3.3% on VYVANSE Generics, Raises Full-Year Forecast

Takeda Pharmaceutical Co. (TYO: 4502, NYSE: TAK) reported third‑quarter fiscal 2025 revenue of 3,411.2 billion yen (USD 22.17 billion), down...